Edwards Lifesciences (EW) insider Zovighian details recent $2.83M stock sale in Form 144

Rhea-AI Filing Summary

Edwards Lifesciences Corporation insider Bernard J. Zovighian filed a notice of proposed disposition of common stock under Form 144, naming Charles Schwab & Co., Inc. as broker. The filing also lists prior sales of 36,351 shares for $2,833,013.00 on May 12, 2026 and 523 shares for $45,982.00 on June 17, 2026.

Key Figures

Recent sale 1 shares: 36,351 shares Recent sale 1 value: $2,833,013.00 Recent sale 2 shares: 523 shares +2 more

5 metrics

Recent sale 1 shares 36,351 shares Common stock sale on 05/12/2026

Recent sale 1 value $2,833,013.00 Proceeds from 36,351-share sale on 05/12/2026

Recent sale 2 shares 523 shares Common stock sale on 06/17/2026

Recent sale 2 value $45,982.00 Proceeds from 523-share sale on 06/17/2026

Broker address zip 76262 ZIP code for Charles Schwab & Co., Inc. in Westlake, TX

Key Terms

Form 144, Exercise & Hold, ESPP, common stock

4 terms

Form 144 regulatory

"insider Bernard J. Zovighian filed a notice of proposed disposition of common stock under Form 144"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

Exercise & Hold financial

"Common | 02/12/2026 | Exercise & Hold | EDWARDS LIFESCIENCES CORPORATION"

ESPP financial

"Common | 09/30/2015 | ESPP - See Remarks | EDWARDS LIFESCIENCES CORPORATION"

An Employee Stock Purchase Plan (ESPP) is a company program that lets employees buy the company’s shares at a reduced price, usually by setting aside a small portion of their pay over time. It matters to investors because it encourages employees to own part of the business—like giving staff a discounted membership— which can boost commitment and performance, while also potentially increasing the number of shares available and affecting shareholder value.

common stock financial

"proposed disposition of common stock under Form 144"

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 07/27/2026 - 04:08 PM Accepted by SEC EDGAR 07/27/2026 - 04:08 PM Learn about SEC filing dates

FAQ

What does Edwards Lifesciences (EW) report in this Form 144 filing?

The filing reports a planned disposition of Edwards Lifesciences common stock by insider Bernard J. Zovighian and lists a broker, Charles Schwab & Co., Inc., along with recent share sale history.

Who is the reporting person in the Edwards Lifesciences (EW) Form 144?

The reporting person is Bernard J. Zovighian, with an address at ONE EDWARDS WAY, IRVINE, CA 92614. The notice relates to proposed sales of Edwards Lifesciences Corporation common stock.

Which broker is named in the Edwards Lifesciences (EW) Form 144?

The broker named is Charles Schwab & Co., Inc., located at 3000 Schwab Way, Westlake, TX 76262. The filing associates Schwab with handling potential sales of Edwards Lifesciences common stock.

What prior stock sales by Bernard Zovighian are disclosed for Edwards Lifesciences (EW)?

The filing lists sales of 36,351 shares for $2,833,013.00 on May 12, 2026 and 523 shares for $45,982.00 on June 17, 2026, both in Edwards Lifesciences Corp common stock.

What types of securities are referenced for Edwards Lifesciences (EW) in this Form 144?

The Form 144 references common stock of Edwards Lifesciences Corporation, including positions tied to an Exercise & Hold transaction dated February 12, 2026 and an ESPP entry dated September 30, 2015.

Does the Edwards Lifesciences (EW) Form 144 specify recent sale dates and amounts?

Yes. It specifies recent sales on May 12, 2026 of 36,351 shares for $2,833,013.00 and on June 17, 2026 of 523 shares for $45,982.00, both involving Edwards Lifesciences common stock.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Charles Schwab & Co., Inc. 3000 Schwab Way Westlake TX 76262	2921	245134.00	575800000	07/27/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	02/12/2026	Exercise & Hold	EDWARDS LIFESCIENCES CORPORATION			2920	02/12/2026	Cash
Common	09/30/2015	ESPP - See Remarks	EDWARDS LIFESCIENCES CORPORATION			1	09/30/2015	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Bernard J Zovighian ONE EDWARDS WAY IRVINE CA 92614	Edwards Lifesciences Corp	05/12/2026	36351	2833013.00
Bernard J Zovighian ONE EDWARDS WAY IRVINE CA 92614	Edwards Lifesciences Corp	06/17/2026	523	45982.00

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)